North Rock Partners, LLC Vericel Corp Transaction History
North Rock Partners, LLC
- $3.04 Billion
- Q4 2024
A detailed history of North Rock Partners, LLC transactions in Vericel Corp stock. As of the latest transaction made, North Rock Partners, LLC holds 5,402 shares of VCEL stock, worth $240,389. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,402Holding current value
$240,389% of portfolio
0.01%Shares
9 transactions
Others Institutions Holding VCEL
# of Institutions
292Shares Held
49.4MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$359 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$155 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$144 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$107 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$99.6 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.1B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...